Tealium for Pharma utilizes deep integration technology and partnerships to deliver an enhanced customer journey in one of healthcare's most vital sectors
The NTM-001 Phase I clinical study is expected to be completed by the end of 2022
The region's digital health market, valued at USD 40.3 billion in 2021, is expected to expand to USD 326.7 billion by 2030 at a CAGR of 26.5 per cent.
Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.
WuXi STA opens a new large scale continuous manufacturing plant
Merck’s first microbiology application and training lab in India
DS-7300 is a specifically designed potential first-in-class B7-H3 directed antibody drug conjugate
The company now exceeds the sector benchmark for its overall ESG rating and for all three measures
Subscribe To Our Newsletter & Stay Updated